These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 2809756

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.
    Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC.
    J Nucl Med; 1989 Nov; 30(11):1902-10. PubMed ID: 2809757
    [Abstract] [Full Text] [Related]

  • 3. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J, Demonceau G, Walovitch RC.
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Technetium-99m-ECD brain SPECT in misery perfusion.
    Shimosegawa E, Hatazawa J, Aizawa Y, Shouji Y, Hachiya T, Murakami M.
    J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448
    [Abstract] [Full Text] [Related]

  • 7. Extraction and retention of technetium-99m-ECD in human brain: dynamic SPECT and oxygen-15-water PET studies.
    Ishizu K, Yonekura Y, Magata Y, Okazawa H, Fukuyama H, Tanaka F, Hattori N, Kitano H, Fujita T, Tamaki N, Konishi J.
    J Nucl Med; 1996 Oct; 37(10):1600-4. PubMed ID: 8926507
    [Abstract] [Full Text] [Related]

  • 8. Formulation of a single-component kit for the preparation of technetium-99m labelled ethyl cysteinate dimer: biological and clinical evaluation.
    Afshan A, Jehangir M, Ashraf M, Waqar A, Chiotellis E.
    Eur J Nucl Med; 1994 Sep; 21(9):991-5. PubMed ID: 7995295
    [Abstract] [Full Text] [Related]

  • 9. [Phase I clinical study of 99mTc-ECD].
    Kubo A, Nakamura K, Tsukatani Y, Sanmiya T, Shimizu S, Yokoyama K, Hashimoto S, Torizuka K.
    Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082
    [Abstract] [Full Text] [Related]

  • 10. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
    Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, Matoba N, Magata Y, Tamaki N, Konishi J.
    J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers.
    Walovitch RC, Franceschi M, Picard M, Cheesman EH, Hall KM, Makuch J, Watson MW, Zimmerman RE, Watson AD, Ganey MV.
    Neuropharmacology; 1991 Mar; 30(3):283-92. PubMed ID: 1906585
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.
    Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA.
    J Nucl Med; 1987 Feb; 28(2):191-202. PubMed ID: 3492596
    [Abstract] [Full Text] [Related]

  • 14. Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects.
    Ichise M, Golan H, Ballinger JR, Vines D, Blackman A, Moldofsky H.
    J Nucl Med; 1997 Aug; 38(8):1253-60. PubMed ID: 9255160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction.
    Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gherardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM.
    J Nucl Med; 1989 Jun; 30(6):1018-24. PubMed ID: 2661751
    [Abstract] [Full Text] [Related]

  • 17. Brain PET and technetium-99m-ECD SPECT imaging in Lhermitte-Duclos disease.
    Ogasawara K, Yasuda S, Beppu T, Kobayashi M, Doi M, Kuroda K, Ogawa A.
    Neuroradiology; 2001 Nov; 43(11):993-6. PubMed ID: 11760808
    [Abstract] [Full Text] [Related]

  • 18. Comparison of technetium-99m-ECD to Xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities.
    Devous MD, Payne JK, Lowe JL, Leroy RF.
    J Nucl Med; 1993 May; 34(5):754-61. PubMed ID: 8478707
    [Abstract] [Full Text] [Related]

  • 19. Importance of the two ester functions for the brain retention of 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD).
    Vanbilloen HP, Cleynhens BJ, Verbruggen AM.
    Nucl Med Biol; 1998 Aug; 25(6):569-75. PubMed ID: 9751425
    [Abstract] [Full Text] [Related]

  • 20. A neutral lipophilic technetium-99m complex for regional cerebral blood flow imaging.
    Narra RK, Nunn AD, Kuczynski BL, DiRocco RJ, Feld T, Silva DA, Eckelman WC.
    J Nucl Med; 1990 Aug; 31(8):1370-7. PubMed ID: 2384806
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.